Curve progression risk in a mixed series of braced and nonbraced patients with idiopathic scoliosis related to skeletal maturity assessment on the olecranon

被引:18
|
作者
Charles, Yann Philippe [1 ]
Canavese, Federico [2 ]
Dimeglio, Alain [3 ]
机构
[1] Univ Hosp Strasbourg, Dept Spine Surg, BP 426, F-67091 Strasbourg, France
[2] Univ Hosp Clermont Ferrand, Dept Pediat Surg, Clermont Ferrand, France
[3] Univ Montpellier, Fac Med, Montpellier, France
来源
关键词
idiopathic scoliosis; olecranon method; peak height velocity; progression risk; pubertal growth spurt; Risser; 0; skeletal age; PEAK HEIGHT VELOCITY; PUBERTAL GROWTH; JUVENILE SCOLIOSIS; GIRLS; AGE; PREDICTION; SYSTEM;
D O I
10.1097/BPB.0000000000000410
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
We aimed to determine the curve progression risk of idiopathic scoliosis in patients at the time of peak height velocity by plotting curve magnitudes against olecranon stages of skeletal maturation. Register data of 372 patients with juvenile or adolescent idiopathic scoliosis followed at 6-month intervals from onset of scoliosis to skeletal maturity were reviewed. At the onset of the pubertal growth spurt, curves greater than 30 degrees have a 100% risk of progressing over 45 degrees (P < 0.0001). Curves 21-30 degrees have a progression risk of 72.5% (P = 0.0034). A curve progression velocity 6-10 degrees per year represents a risk of 71.8% (P = 0.0001) to require surgical treatment and a velocity greater than 10 degrees per year represents a risk of 100% (P < 0.0001). Plotting curve magnitudes against height measurements and the stages of olecranon maturation offers a reliable prediction of curve progression risk in idiopathic scoliosis during Risser 0. Copyright (C) 2017 Wolters Kluwer Health, Inc. All rights reserved.
引用
收藏
页码:240 / 244
页数:5
相关论文
共 21 条
  • [21] Potential Muscle-Related Biomarkers in Predicting Curve Progression to the Surgical Threshold in Adolescent Idiopathic Scoliosis-A Pilot Proteomic Study Comparing Four Non-Progressive vs. Four Progressive Patients vs. A Control Cohort
    Wang, Yujia
    Chen, Huanxiong
    Zhang, Jiajun
    Lam, Tsz-ping
    Hung, A. L. H.
    Cheng, J. C. Y.
    Lee, W. Y. W.
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (21)